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Abstract
Background: Studies have shown that pistachios can improve blood lipid profiles in subjects with moderate
hypercholesterolemia which could reduce the risk of cardiovascular disease. However, there is also a widely
perceived view that eating nuts can lead to body weight gain due to their high fat content.
Purpose: To investigate the impact of different dosages of pistachios on body weight, blood pressure, blood lipids,
blood glucose and insulin in subjects with metabolic syndrome.
Methods: Ninety subjects with metabolic syndrome (consistent with 2005 International Diabetes Federation
metabolic syndrome standard without diabetes) were enrolled in three endocrinology outpatient clinics in Beijing.
All subjects received dietary counseling according to the guidelines of the American Heart Association Step I diet.
After a 4 week run-in, subjects were randomized to consume either the recommended daily serving of 42 g
pistachios (RSG), a higher daily serving of 70 g pistachio (HSG) or no pistachios (DCG) for 12 weeks.
Results: Subjects in all three groups were matched at baseline for BMI: DCG 28.03 ± 4.3; RSG 28.12 ± 3.22; and
HSG 28.01 ± 4.51 kg/m
2. There were no significant changes in body weight or BMI in any groups during the study
nor any change from baseline at any time point in any group. During the entire study, there were no significant
differences in waist-to-hip ratio among the groups or any change from baseline in any group (DCG -0.00 ± 0.03,
RSG -0.01 ± 0.02 and HSG 0.01 ± 0.04). There were no significant differences detected among groups in
triglycerides, fasting glucose and 2 hour postprandial glucose following a 75 gram glucose challenge. Exploratory
analyses demonstrated that glucose values 2 h after a 75 gm glucose challenge were significantly lower at week
12 compared with baseline values in the HSG group (-1.13 ± 2.58 mmol/L, p = 0.02), and a similar trend was noted
in the RSG group (-0.77 ± 2.07 mmol/L, p = 0.06), while no significant change was seen in the DCG group (-0.15 ±
2.27 mmol/L, p = 0.530). At the end of study, serum triglyceride levels were significantly lower compared with
baseline in the RSG group (-0.38 ± 0.79 mmol/L, p = 0.018), but no significant changes were observed in the HSG
or DCG groups.
Conclusion: Despite concerns that pistachio nut consumption may promote weight gain, the daily ingestion of
either 42 g or 70 g of pistachios for 12 weeks did not lead to weight gain or an increase in waist-to-hip ratio in
Chinese subjects with metabolic syndrome. In addition, pistachio consumption may improve the risk factor
associated with the metabolic syndrome.
Introduction
Metabolic syndrome (MS) is a cluster of cardiovascular
risk factors, including abdominal obesity, increased
blood pressure, and blood glucose and lipid abnormal-
ities often characterized as prediabetes. Obesity and
metabolic syndrome are increasingly common in
developing nations, including East Asian countries such
as China, Japan, and Korea [1] and are associated with
diabetes and increased cardiovascular disease mortality
[2].
Epidemiological evidence has shown that frequent
ingestion of nuts is beneficial in helping to reduce risk
factors for coronary heart disease [3-5]. Increased con-
sumption of pistachios has been shown to improve
blood glucose level, endothelial function, and some
indices of inflammation and oxidative status in healthy
* Correspondence: ywy_1010@yahoo.com.cn
1Department of Endocrinology, Sino-Japan Friendship Hospital, Beijing
100029, China
Full list of author information is available at the end of the article
Wang et al. Nutrition Journal 2012, 11:20
http://www.nutritionj.com/content/11/1/20
© 2012 Wang et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.young men [6]. In subjects with moderate hypercholes-
terolemia pistachio consumption has been shown to
improve blood lipids abnormalities [7]. Some of these
beneficial effects may be related to the antioxidants
naturally present in pistachio, since pistachio consump-
tion has been shown to reduce oxidative stress markers
in healthy subjects [8].
There is a widely held view that, due to its high fat
content, nut consumption may lead to weight gain in
the population at large especially in obese subjects and
those with MS profiles. Li et al reported that the daily
consumption of a defined quantity of pistachio nuts,
when compared to an isocaloric refined carbohydrate
snack, did not interfere with weight loss and improved
triglyceride levels in an outpatient weight loss trial in
the US [9]. However, there has not been a study of the
impact of pistachio consumption on body weight and
other risk factors for metabolic syndrome in Chinese
patients. The present study evaluated the impact of daily
consumption of no pistachios or two different amounts
of pistachios on body weight gain, and various risk fac-
tors related to metabolic syndrome in Chinese subjects.
Methods
Subjects
The study protocol was approved by ethics committees
at each of the participating hospitals. Written informed
consent was obtained from the patient for publication of
this report and any accompanying images.
Male and female subjects 25 to 65 years of age who
also met the 2005 International Diabetes Federation
(IDF) metabolic syndrome standards for a Chinese
population [presence of three of the following risk fac-
tors of fasting serum triglyceride > 150 mg/dl, abdom-
inal obesity (waist circumference > 90 cm in males or >
80 cm in females) or hypertension (SBP:≥130 or DBP ≥
85 mmHg or history of treatment with anti-hypertensive
agents) or impaired glucose tolerance (FPG > 100 mg/
dl/or PPG > 140 and < 200 mg/dl) or low HDL-C (< 40
mg/dl in males or < 50 mg/dl in females)] and without
diabetes were enrolled in three endocrinology outpatient
clinics in Beijing, China. Subjects with type 2 diabetes,
triglycerides > 500 mg/dL, LDL-C > 160 mg/dL, uncon-
trolled hypertension, hypothyroidism, Cushing’s disease,
polycystic ovarian syndrome, acute infectious disease or
chronic diseases in liver, kidneys, heart, lungs or other
organs were excluded.
All eligible subjects completed a four week run-in per-
iod to monitor the stability of vital signs, body weight
and compliance. Subjects were given information on
American Heart Association Steep 1 diet, not to con-
sume any tree nuts. Any subjects with weight change ≥
1 kg during the run-in was excluded from the study.
A randomization scheme was generated, and after the
run-in period, subjects from each site were randomly
assigned to one of the following three groups: recom-
mended serving pistachio group (pistachios 42 g daily,
RSG), high serving pistachio group (pistachios 70 g
daily, HSG) and diet control group (DCG) with no pis-
tachios Pistachio nuts were supplied in pre-portioned
packets (Paramount Farms, Inc., Los Angeles, CA
90064) and were distributed to the subjects in interven-
tion groups at each study visit at weeks 2, 4, 6,8,10 and
12. Subjects were instructed to consume pistachio as an
afternoon snack.
All subjects were counseled on healthy eating at each
visit according to the guidelines of the American Heart
Association Step I diet. Subjects were asked not to con-
sume any tree nuts other than those provided by the
study. Subjects were instructed not to change their
usual activity and exercise during the entire study per-
iod. A random phone call was conducted every 2 weeks
for compliance of taking pistachio, following study
instruction on diet and activity.
Anthropometric measurements
The body weight and vital signs were measured at every
study visit. Subjects were weighed at each visit on the
same scale (RGZ-120-RT, Zeast Hangzhou, China) in
light garments, barefoot and after an overnight fast.
Height was measured with a stadiometer at week 0.
BMI was calculated as weight (kg)/height squared (m).
Waist circumference was measured midway between
iliac crest and the lowermost margin of the rib. Hip cir-
cumference was measured at the maximum circumfer-
ence of the buttocks with the subject standing with the
feet placed together. Blood pressure was measured
manually with subjects in a sitting position after resting
> 10 minutes.
Biochemistry
Blood samples were taken after 10-12 hours of fasting at
baseline, and at weeks 6 and 12. Insulin was measured
using an established radioimmunoassay in the endocri-
nology laboratory of China-Japan Friendship Hospital
and the other indicators were measured in the clinical
laboratories at each study location. Total cholesterol, tri-
glycerides, and HDL were determined using standard
enzymatic methods using a Roche Hitachi™ Analyzer
and RANDOX reagents. LDL cholesterol was estimated
from these data using the Friedewald equation. An oral
glucose tolerance test (OGTT) was performed at base-
line, and at weeks 6 and 12. A glucose challenge of 75 g
was administered after a 10-12-hour fast, and blood glu-
cose and insulin were measured at time 0, 1 hour and 2
hours. AST and ALT were measured with commercial
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eration of Clinical Chemistry and Laboratory Medicine
(IFCC) recommended reference measurement systems
using a Roche Hitachi™ Analyzer and RANDOX
reagents.
Data management and statistical analyses
All data management and statistical analyses were per-
formed using SAS 9.13 software. Data were expressed as
least squares mean ± standard deviation and checked
for normality. The values reported were non-adjusted
values. The difference of each indicator value before and
after the experiment was measured by paired t test
while the differences between groups were tested by
analysis of variance. Confidence levels for significance
were P < 0.05.
Results
Subjects
Ninety subjects who met the inclusion criteria were ran-
domized to the study. The subject demographics and
metabolic profiles are summarized in Table 1. The RSG
group included 16 males and 14 females, with an aver-
age age of 51.89 ± 8.82 years, the HSG group included
12 males and 18 females, with an average age of 51.83 ±
9.37 years; and the DCG group included 13 males and
17 females, with an average age of 50.66 ± 9.86 years.
There were no differences in the average age or gender
distribution of the groups at the time of enrollment.
There were no differences among the groups in mean
body mass index (BMI), waist and hip circumference,
fasting glucose, insulin or blood lipid levels (Table 1).
Of the 90 randomized subjects, 86 subjects completed
the study. Four subjects dropped out of the study, two
subjects in RSG group and one subject in the HSG
group were lost to follow up, and one patient in RSG
group withdrew from the study due to a diagnosis of
diabetes that required treatment. There were no signifi-
cant adverse events reported.
Body weight and waist/hip ratio
T h eb o d yw e i g h ta tb a s e l i n ew a sw e l lm a t c h e da m o n g
the three groups. There were no significant changes in
mean body weight in any of the groups over the course
of the study or at any study point. (Figure 1A). BMI at
baseline in the three groups were 28.03 ± 4.3, 28.12 ±
3.22, and 28.01 ± 4.51 kg/m
2 in the DCG, RSG and
HSG groups, respectively. There was no significant
change in BMI from baseline at any time point in any of
the groups. (Figure 1B). At Week 12, there were no sig-
nificant changes from baseline in waist-to-hip ratio for
the subjects in any groups (RSG - 0.01 ± 0.02, HSG 0.01
± 0.04, DCG - 0.0 ± 0.03). (Figure 2)
Blood pressure
T h eb a s e l i n es y s t o l i ca n dd i a s t o l i cb l o o dp r e s s u r ew e r e
within a normal blood pressure range and without dif-
ferences among the groups (systolic blood pressure
Table 1 Demographic and metabolic status of study
subjects at baseline
Index RSG (n =
30)
HSG (n =
30)
DCG (n =
30)
Age 51.89 ± 8.82 51.83 ± 9.37 50.66 ± 9.86
Gender Male (53%) Male (40%) Male (43%)
Female (47%) Female (60%) Female (57%)
BMI (kg/m
2) 28.12 ± 3.22 28.01 ± 4.51 28.03 ± 4.35
Waist-to-hip ratio 0.93 ± 0.06 0.92 ± 0.06 0.92 ± 0.07
Fasting Glucose (mmol/L) 5.30 ± 0.85 5.18 ± 0.71 5.27 ± 0.79
Fasting Insulin (mU/L) 14.13 ± 6.89 17.08 ± 13.75 16.74 ± 14.81
Total cholesterol (mmol/
L)
5.29 ± 1.01 5.29 ± 0.93 5.01 ± 0.99
Triglyceride (mmol/L) 2.47 ± 1.28 2.19 ± 0.76 3.11 ± 3.45
LDL(mmol/L) 3.08 ± 0.70 3.00 ± 0.70 2.70 ± 0.90
HDL (mmol/L) 1.15 ± 0.28 1.27 ± 0.30 1.05 ± 0.26
Analysis of variance was used for comparisons among the groups.
A 
 
B
Figure 1 Body weight (A) and BMI (B) in 12 weeks.-◆-d i e t a r y
control group (DCG), -■-recommended serving of pistachio (RSG),
-▲-high serving of pistachio (HSG). BMI was calculated as body
weight in kilograms divided by the square of height in cm.
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mmHg for RSG, HSG, DCG groups; diastolic blood
pressure was 81.1 ± 10.6, 81.7 ± 9.1, and 79.3 ± 7.3
mmHg for RSG, HSG, DCG groups, respectively)(Fig-
u r e3 ) .T h e r ew e r en os i g n i ficant differences among
the groups during the 12 week study period. In a sec-
ondary analysis the diastolic blood pressure in the RSG
group at week 10 was lower than at baseline by 4.96 ±
10.1 mmHg (p = 0.017).
Blood glucose and insulin levels
T h ef a s t i n gb l o o dg l u c o s el e v e l sa tb a s e l i n ew e r e5 . 3 0±
0.85, 5.18 ± 0.71, and 5.27 ± 0.79 mmol/L for RSG,
HSG and DCG, respectively. There were no significant
differences in values among the groups. Compared with
baseline values, blood glucose increased significantly in
the control group at week 12 (0.32 ± 0.65 mmol/L, p =
0.014) but not in the two pistachio groups (RSG 0.14 ±
0.68 mmol/L (p = 0.296); HSG 0.04 ± 0.74 mmol/L (p =
0.758). Blood glucose measured 2 hours after a 75 g glu-
cose challenge were no statistical differences among the
groups (p = 0.530) (Table 2) at baseline and end of the
study. At week 12, the post challenge blood glucose
decreased significantly from baseline in the HSG group
(-1.13 mmol/L, p = 0.028) but there was no change in
the DCG group (-0.15 mmol/L, p =0 . 7 1 8 )a n do n l ya
non-significant downward trend in the RSG group
(-0.77 mmol/L p = 0.064).
Blood lipids
There was no significant difference among the three
groups in total cholesterol, triglycerides, LDL or HDL
over the course of the study (Table 3). The triglycerides
were within normal range at baseline (RSG 2.47 ± 1.28
mmol/L; HSG 2.19 ± 0.76 mmol/L; and DCG 2.09 ±
0.78 mmol/L). Triglyceride levels in the RSG group
were lower at week 6 (-0.12 ± 1.06 mmol/L, p = 0.549)
and decreased significantly from baseline by week 12
(-0.38 ± 0.79 mmol/L, p = 0.018). Compared with base-
line values, the low density lipoprotein cholesterol
(LDL) level was increased at week 12 for HSG (0.31 ±
0.51 mmol/L, p = 0.003) and DCG (0.29 ± 0.74 mmol/L,
p =0 . 0 3 7 )b u tn o tf o rR S G( 0 . 1 2±0 . 5 0m m o l / L ,p =
0.231). There was a 0.09 mmol/L decrease in LDL after
6 weeks in RSG compared to a 0.12 mmol/L increase in
LDL for the DCG. There was no significant change in
total cholesterol or high density cholesterol from base-
line in any of the three groups.
Liver function tests
Alanine transaminase (ALT) and Aspartate transaminase
(AST) were measured. There was no significant change
in ALT values during the study in any of the groups.
The AST level remained at the same level for the con-
trol group but significantly decreased at week 12 for
both pistachio groups (RSG - 7.81 ± 12.60 U/L, p =
0.003; HSG -5.52 ± 13.90 U/L, p = 0.041).(Table 4)
Figure 2 Waist/hip ratio in 12 weeks.- ♦- dietary control group
(DCG), -■- recommended serving of pistachio (RSG), -▲-high serving
of pistachio (HSG).
A 
 
B 
Figure 3 Systolic (A) and diastolic (B) blood pressure in 12
weeks. Systolic (A) and diastolic (B) blood pressure in 12 weeks. -♦-
dietary control group (DCG), -■- recommended serving of pistachio
(RSG), -▲-high serving of pistachio (HSG)
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Studies have shown that nut consumption is of benefit
in the prevention of cardiovascular disease [10]. In a
health claim approved by US FDA in July 2003, it was
stated that “Scientific evidence suggests, but does not
prove, that eating 1.5 ounces per day of most nuts, such
as pistachio, as part of a diet low in saturated fat and
cholesterol, may reduce the risk of heart disease.”
There has been concern that consumption of pista-
chios may lead to increased calorie intake and body
weight gain due to its fat content. If true, this finding
would suggest that patients with metabolic syndrome
should limit their intake of pistachios. Consumption of
excess calories is of particular concern in Chinese indi-
viduals who have an overall lower BMI and basal
metabolic rate compared to Western populations
[11-13]. Our results indicate that the daily consump-
tion of either a high dose or recommended dose of
pistachio nuts for 12 weeks, when compared with a
control group, resulted in no changes in body mass
index or waist-to-hip ratio. These results were consis-
tent with the results of previous studies in other popu-
lations [7,14]. In a 12 week parallel study of 118
subjects in which nuts were compared to other energy-
dense snacks, nuts improved diet quality without any
negative impact on body weight or lipid values [15].
The study conducted by Coates and Howe [16] indi-
cated that nuts may be helpful for the regulation of
body weight by inhibiting appetite and fat absorption.
Studies have suggested that the lipid in nuts is more
poorly absorbed than from other food sources. Baer et
al reported that the measured energy density of pista-
c h i o sw a s2 2 . 6k J / g ,w h i c hi s5 %l e s st h a nt h ec u r r e n t l y
accepted energy value of 23.7 kJ/g, as calculated using
the Atwater general factors [17].
Pistachios have a low glycemic index. The study con-
ducted by Josse [18] indicated that, when taken together
with high carbohydrate foods, pistachio nuts decreased
the absorption of carbohydrate, and lowered postpran-
dial blood glucose. In the present study the primary ana-
lysis did not show any difference among groups but the
secondary analysis did demonstrate that consuming 70
gram of pistachio nuts significantly lowered 2 hour
blood glucose values after a 75 gram glucose challenge
in subjects with metabolic syndrome.
It has been shown that nuts are not only beneficial in
improving the blood lipid profile, but may also prevent
coronary heart disease through the other mechanisms
[5]. Hypertension is one of the criteria of metabolic syn-
drome. In this study the consumption of pistachios did
not lead to increased blood pressure in patients with
metabolic syndrome, consistent with prior study results
[7,14].
Aminotransferase levels in obesity are associated with
insulin resistance and the metabolic syndrome [19,20].
The AST level in our study was significantly lowered by
consume pistachio. Pistachio nuts are rich in monounsa-
turated fatty acids, antioxidants such as vitamin E,
lutein, b-carotene, and proanthocyanidins. Those nutri-
ents have antioxidant properties [8,21], and may offer
protection against oxidative stress in liver.
The purpose of the study was to demonstrate that pis-
tachios do not cause weight gain predicted from their
fat content in a free living population. The dietary
intake and activity level wer en o tc o n t r o l l e dt h a tw a s
the limitation of current study. Although our secondary
Table 2 Changes of blood glucose and insulin from baseline at week 12
Indicator RSG (n = 27) Change HSG (n = 29) Change DCG (n = 30) Change
baseline week 12 baseline week 12 baseline week 12
GLU0h(mmol/
L)
5.30 ± 0.85 5.41 ± 0.63 0.14 ± 0.68 5.18 ± 0.71 5.20 ± 0.60 0.04 ± 0.74 5.27 ± 0.79 5.57 ± 0.90 0.32 ± 0.65*
GLU2h(mmol/
L)
8.16 ± 2.76 7.10 ± 2.08 - 0.77 ± 2.07 7.66 ± 2.08 6.66 ± 2.11 - 1.13 ±
2.58**
7.42 ± 2.00 7.27 ± 2.16 - 0.15 ± 2.27
Insulin 0h(mu/
L)
14.13 ± 6.89 14.41 ± 8.68 0.47 ± 4.44 17.08 ±
13.75
14.68 ± 6.86 - 2.08 ± 14.54 16.74 ±
14.81
18.66 ±
22.48
1.93 ± 12.68
Insulin 2h(mu/
L)
94.42 ±
78.42
83.50 ±
56.16
- 7.46 ±
50.52
83.80 ±
49.56
81.40 ±
42.14
- 11.10 ±
70.27
94.32 ±
84.18
81.99 ±
60.83
- 12.33 ±
55.59
t test was used for comparisons with baseline, * p < 0.05, ** p < 0.01.
Table 3 Change of blood lipids level
Parameter RSG (n = 27) Change HSG (n = 29) Change DCG (n = 30) Change
baseline week 12 baseline week 12 baseline week 12
TC (mmol/L) 5.29 ± 1.01 5.20 ± 0.94 -0.01 ± 0.67 5.29 ± 0.93 5.41 ± 1.06 0.11 ± 0.69 5.01 ± 0.99 5.15 ± 1.04 0.14 ± 0.56
TG (mmol/L) 2.47 ± 1.28 2.14 ± 1.03 -0.38 ± 0.79* 2.19 ± 0.76 2.05 ± 0.80 -0.18 ± 0.87 2.09 ± 0.78 1.88 ± 0.89 -0.21 ± 0.53
LDL-C(mmol/L) 3.08 ± 0.70 3.10 ± 0.69 0.12 ± 0.50 3.00 ± 0.70 3.30 ± 0.78 0.31 ± 0.51** 2.70 ± 0.90 2.99 ± 0.86 0.29 ± 0.74*
t test was used for comparisons with baseline, * p < 0.05, ** p < 0.01.
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baseline showed changes of some of the risk factors in
the pistachio groups the study was underpowered to
determine the differences among the groups and should
be repeated in a larger population.
Conclusion
Despite concerns that pistachio nut consumption may
promote weight gain, the daily ingestion of either 42 g
or 70 g of pistachios for 12 weeks does not lead to
weight gain or an increase in waist-to-hip ratio in Chi-
nese subjects with metabolic syndrome. In addition, pis-
tachio consumption may also improve risk factors
associated with the metabolic syndrome.
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